Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities (Review)

Int J Oncol. 2021 Nov;59(5):85. doi: 10.3892/ijo.2021.5265. Epub 2021 Sep 17.

Abstract

Lactoferrin (Lf) is secreted by ectodermal tissue and has a structure similar to that of transferrin. Although Lf seems to be multifunctional, its main function is related to the natural defense system of mammals. The present review aims to highlight the major actions of Lf, including the regulation of cell growth, the inhibition of toxic compound formation, the removal of harmful free radicals and its important role in immune response regulation. Moreover, Lf has antibacterial, antiviral, antioxidant, anticancer and anti‑inflammatory activities. In addition, the use of Lf for functionalization of drug nanocarriers, with emphasis on tumor‑targeted drug delivery, is illustrated. Such effects serve as an important theoretical basis for its future development and application. In neurodegenerative diseases and the brains of elderly people, Lf expression is markedly upregulated. Lf may exert an anti‑inflammatory effect by inhibiting the formation of hydroxyl free radicals. Through its antioxidant properties, Lf can prevent DNA damage, thereby preventing tumor formation in the central nervous system. In addition, Lf specifically activates the p53 tumor suppressor gene.

Keywords: anticancer; anti‑bacterial; central nervous system tumor; immunomodulatory; immunostimulatory; lactoferrin.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Immunomodulating Agents / pharmacology*
  • Lactoferrin / pharmacology*
  • Nanotechnology
  • Neoplasms / prevention & control*

Substances

  • Adjuvants, Immunologic
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Immunomodulating Agents
  • Lactoferrin